Michael D. Taylor
2017
In 2017, Michael D. Taylor earned a total compensation of $1.7M as President and Chief Executive Officer at Deciphera Pharmaceuticals, a 51% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $220,000 |
|---|---|
| Option Awards | $998,654 |
| Salary | $430,400 |
| Other | $8,100 |
| Total | $1,657,154 |
Taylor received $998.7K in option awards, accounting for 60% of the total pay in 2017.
Taylor also received $220K in non-equity incentive plan, $430.4K in salary and $8.1K in other compensation.
Rankings
In 2017, Michael D. Taylor's compensation ranked 6,470th out of 14,666 executives tracked by ExecPay. In other words, Taylor earned more than 55.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,470 out of 14,666 | 56th |
Division Manufacturing | 2,386 out of 5,772 | 59th |
Major group Chemicals And Allied Products | 762 out of 2,075 | 63rd |
Industry group Drugs | 588 out of 1,731 | 66th |
Industry Pharmaceutical Preparations | 464 out of 1,333 | 65th |
Source: SEC filing on April 3, 2018.
Taylor's colleagues
We found two more compensation records of executives who worked with Michael D. Taylor at Deciphera Pharmaceuticals in 2017.